Hyperbaric oxygen therapy for the treatment of late radiation
tissue injury
Abstract
Background
Cancer is a significant global health problem. Radiotherapy is a treatment for
many cancers and about 50% of patients having radiotherapy with be long-term
survivors. Some will experience LRTI developing months or years later. HBOT has
been suggested for LRTI based upon the ability to improve the blood supply to
these tissues. It is postulated that HBOT may result in both healing of tissues
and the prevention of problems following surgery.
Objectives
To assess the benefits and harms of HBOT for treating or preventing LRTI.
Search strategy
We searched The Cochrane Central Register of Controlled Trials (CENTRAL) Issue
3, 2004, MEDLINE, EMBASE, CINAHL and DORCTHIM (hyperbaric RCT register) in
September 2004.
Selection criteria
Randomised controlled trials (RCTs) comparing the effect of HBOT versus no HBOT
on LRTI prevention or healing.
Data collection and analysis
Three reviewers independently evaluated the quality of the relevant trials using
the guidelines of the Cochrane Handbook Clarke
2003) and extracted the data from the included trials.
Main results
Six trials contributed to this review (447 participants). For pooled analyses,
investigation of heterogeneity suggested important variability between trials.
From single studies there was a significantly improved chance of healing
following HBOT for radiation proctitis (relative risk (RR) 2.7, 95% confidence
Interval (CI) 1.2 to 6.0, P = 0.02, numbers needed to treat (NNT) = 3), and
following both surgical flaps (RR 8.7, 95% CI 2.7 to 27.5, P = 0.0002, NNT = 4)
and hemimandibulectomy (RR 1.4, 95% CI 1.1 to 1.8, P = 0.001, NNT = 5). There
was also a significantly improved probability of healing irradiated tooth
sockets following dental extraction (RR 1.4, 95% CI 1.1 to 1.7, P = 0.009, NNT =
4).
There was no evidence of benefit in clinical outcomes with established radiation
injury to neural tissue, and no data reported on the use of HBOT to treat other
manifestations of LRTI. These trials did not report adverse effects.
Authors' conclusions
These small trials suggest that for people with LRTI affecting tissues of the
head, neck, anus and rectum, HBOT is associated with improved outcome. HBOT also
appears to reduce the chance of osteoradionecrosis following tooth extraction in
an irradiated field. There was no such evidence of any important clinical effect
on neurological tissues. The application of HBOT to selected patients and
tissues may be justified. Further research is required to estabish the optimum
patient selection and timing of any therapy. An economic evaluation should be
also be undertaken. There is no useful information from this review regarding
the efficacy or effectiveness of HBOT for other tissues.
Citation: Bennett MH, Feldmeier J, Hampson N, Smee R, Milross C.
Hyperbaric oxygen therapy for late radiation tissue injury. The Cochrane
Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005005. DOI:
10.1002/14651858.CD005005.pub2